The prognostic improvement of add-on bevacizumab for progressive disease during concomitant temozolomide and radiation therapy in the patients with glioblastoma and anaplastic astrocytoma.
CONCLUSIONS: We found that, for patients with GBM/AAs whose tumors were continuously growing during radiotherapy, add-on BEV treatment resulted in survival benefits.
PMID: 30035459 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgical Sciences - Category: Neurosurgery Tags: J Neurosurg Sci Source Type: research
More News: Astrocytoma | Avastin | Brain | Brain Tumor | Chemotherapy | Clinical Trials | Glioma | Japan Health | Neurology | Neurosurgery | Radiation Therapy | Study | Temodar